Anika Therapeutics ANIK Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's other non-current liabilities?
- Anika Therapeutics (ANIK) reported other non-current liabilities of $726K in Q1 2026.
- How has Anika Therapeutics's other non-current liabilities changed year-over-year?
- Anika Therapeutics's other non-current liabilities decreased by 2.4% year-over-year, from $744K to $726K.
- What is the long-term trend for Anika Therapeutics's other non-current liabilities?
- Over 5 years (2020 to 2025), Anika Therapeutics's other non-current liabilities has grown at a -10.8% compound annual growth rate (CAGR), from $1.24M to $701K.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.